Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder

Gynecologic Oncology
Sami TsukishiroKaoru Suzumori

Abstract

To assess the clinical relevance of serum regulated upon activation, normal T-cell expressed and secreted (RANTES) levels in distinguishing patients with ovarian cancers from those with benign ovarian cysts, we measured its concentration with reference to the disease stage, pathological grading, histological subtype, and the residual tumor mass. Preoperative serum RANTES levels were measured in women with invasive epithelial ovarian cancer (n = 52), borderline ovarian tumor (n = 6), benign ovarian cysts (n = 28), or normal controls (n = 12) using an enzyme-linked immunosorbent assay. The serum RANTES concentration was significantly elevated in the ovarian cancer patients (median 53 ng/ml, interquartile range 23-104 ng/ml) compared to the benign ovarian cyst patients as controls (38 ng/ml, 5-72 ng/ml) values correlating with the stage of disease and the extent of residual tumor mass. No significant correlation between CA125 and RANTES in the serum was observed in either the controls or the ovarian cancer patients. Using a RANTES cutoff of 45 ng/ml and a CA125 cutoff of 35 units/ml, when either marker was elevated, the specificity improved 94%. Our study suggest that preoperative serum RANTES levels may be useful in differentiati...Continue Reading

References

May 1, 1995·The Journal of Clinical Investigation·R P NegusF R Balkwill
Jul 1, 1996·Cytokine·F BurkeF Balkwill
Feb 3, 1997·The Journal of Experimental Medicine·R L Coffman, T von der Weid
Mar 20, 2002·Cytokine & Growth Factor Reviews·Alain P Vicari, Christophe Caux
May 25, 2002·Seminars in Cancer Biology·Julia Wilson, Fran Balkwill
Jun 12, 2003·American Journal of Reproductive Immunology : AJRI·Hiroaki ShibaharaIkuo Sato
Oct 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Katherine R KozakRobin Farias-Eisner

❮ Previous
Next ❯

Citations

Feb 14, 2014·Mediators of Inflammation·Donatella Aldinucci, Alfonso Colombatti
Jan 23, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haixia DingBaoen Shan
Aug 21, 2013·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Kee Hwan KwonYoung Gyu Eun
Aug 6, 2008·Molecular & Cellular Proteomics : MCP·Christopher LaustedLeroy Hood
Feb 5, 2013·Cellular & Molecular Immunology·Dandan LvXiaojing Ma
Jan 24, 2018·Scientific Reports·Santosh Kumar SinghRajesh Singh
Feb 26, 2008·Journal of Surgical Oncology·Hidekazu SugasawaHidetaka Mochizuki
Apr 12, 2007·Expert Review of Proteomics·Ruo-Pan Huang
Nov 7, 2019·Molecular Biology Reports·Daniela Rudgeri DerossiIlce Mara de Syllos Cólus
May 19, 2018·International Journal of Molecular Sciences·Donatella Aldinucci, Naike Casagrande
Jul 8, 2020·Cancers·Donatella AldinucciNaike Casagrande
Jul 12, 2019·Cancer Research·Xuanmao JiaoRichard G Pestell
Nov 28, 2020·International Journal of General Medicine·Yudi Mulyana HidayatSiti Salima
Jan 20, 2021·Clinical and Translational Medicine·Neng WangZhiyu Wang
Feb 20, 2021·Cancer Gene Therapy·Karan KohliTeresa S Kim
Oct 15, 2021·Journal for Immunotherapy of Cancer·Jitka FucikovaRadek Spisek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved